Related Experiment Video
Updated: May 17, 2026

Remote Laboratory Management: Respiratory Virus Diagnostics
Published on: April 6, 2019
Truncated robust distance for clinical laboratory safety data monitoring and assessment
Xiwu Lin1, Daniel Parks, Lei Zhu
1Quantitative Sciences, GlaxoSmithKline Pharmaceuticals R&D, Collegeville, Pennsylvania 19426, USA. xiwu.2.lin@gsk.com
Abstract:
Laboratory safety data are routinely collected in clinical studies for safety monitoring and assessment. We have developed a truncated robust multivariate outlier detection method for identifying subjects with clinically relevant abnormal laboratory measurements. The proposed method can be applied to historical clinical data to establish a multivariate decision boundary that can then be used for future clinical trial laboratory safety data monitoring and assessment. Simulations demonstrate that the proposed method has the ability to detect relevant outliers while automatically excluding irrelevant outliers. Two examples from actual clinical studies are used to illustrate the use of this method for identifying clinically relevant outliers.
Related Concept Videos
Therapeutic Drug Monitoring: Drug Analysis Methods
Difference from Background: Limit of Detection
The LOD indicates the presence or absence...
Automated Microbial Diagnostics
